Stock DNA
Medical/Nursing Services
CAD 48 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-5.01
42.28%
-0.14
Revenue and Profits:
Net Sales:
248 Million
(Quarterly Results - Jun 2023)
Net Profit:
-129 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.92%
0%
3.92%
6 Months
107.84%
0%
107.84%
1 Year
-56.91%
0%
-56.91%
2 Years
-71.81%
0%
-71.81%
3 Years
-86.98%
0%
-86.98%
4 Years
-88.43%
0%
-88.43%
5 Years
-88.6%
0%
-88.6%
Akumin, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
39.45%
EBIT Growth (5y)
-7.38%
EBIT to Interest (avg)
0.72
Debt to EBITDA (avg)
11.29
Net Debt to Equity (avg)
-5.01
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.16%
ROE (avg)
1.86%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.14
EV to EBIT
96.90
EV to EBITDA
11.61
EV to Capital Employed
1.28
EV to Sales
1.83
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.32%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Jun 2022
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 25 Foreign Institutions (28.05%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'23 - QoQ
Jun'23
Mar'23
Change(%)
Net Sales
248.30
253.70
-2.13%
Operating Profit (PBDIT) excl Other Income
34.80
42.80
-18.69%
Interest
41.90
41.50
0.96%
Exceptional Items
-76.20
-8.70
-775.86%
Consolidate Net Profit
-129.50
-39.50
-227.85%
Operating Profit Margin (Excl OI)
-49.30%
46.00%
-9.53%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2023 is -2.13% vs 1.20% in Mar 2023
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2023 is -227.85% vs 41.04% in Mar 2023
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
975.90
527.90
84.86%
Operating Profit (PBDIT) excl Other Income
179.70
77.60
131.57%
Interest
153.60
78.50
95.67%
Exceptional Items
-97.30
-24.70
-293.93%
Consolidate Net Profit
-197.30
-43.60
-352.52%
Operating Profit Margin (Excl OI)
53.10%
40.40%
1.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 84.86% vs 60.21% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -352.52% vs 4.80% in Dec 2021






